Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus

QJM

Volumn 68, Issue 1, 1988, Pages 525-531

  Loizou, Sozos ^a   Byron, Margaret A ^b   Englert, Helen J ^a   David, Joel ^a   Hughes, Graham R V ^a   Walport, Mark J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NUFFIELD ORTHOPAEDIC CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CARDIOLIPIN;

ADULT; COMPLICATION; ETIOLOGY; FATALITY; FEMALE; FETUS DEATH; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOANTIBODIES; CARDIOLIPINS; FEMALE; FETAL DEATH; GESTATIONAL AGE; HUMAN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T;

EID: 0023752192     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/oxfordjournals.qjmed.a068219     Document Type: Article

References (23)

1. Fraga A, Mintz G, Orozco J, Orozco JH. Sterility and fertility rates, fetal wastage and maternal morbidity in systemic lupus erythematosus. J Rheumatol 1974; 1: 293-298.
2. Grigor RR, Shervington PC, Hughes, GRV, Hawkins DF. Outcome of pregnancy in systemic lupus erythematosus. Proc R Soc Med 1977; 70: 99-100.
3. Carreras LO, Vermylen JG. “Lupus” anticoagulant and thrombosis - possible role of inhibition of prostacyclin formation. Thromb Haemost 1982; 48: 38-40.
4. Branch DW, Scott JR, Kochenour NK, Hershgold E. Obstetric complications associated with the lupus anticoagulant. N Engl J Med 1985; 313: 1322-1326.
5. Lockshin MD, Harpel PC, Druzin ML, et al. Lupus pregnancy II. Unusual pattern of hypocomplementemia and thrombocytopenia in the pregnant patient. Arthritis Rheum 1985; 28: 58-66.
6. Gardlund B. The lupus inhibitor in thromboembolic disease and intrauterine death in the absence of systemic lupus. Acta Med Scand 1984; 215: 293-298.
7. Lubbe WF, Butler WS, Palmer SJ, Liggins GC. Lupus anticoagulant in pregnancy. Br J Obstet Gynaecol 1984; 91: 357-363.
8. Englert HJ, Derue GM, Loizou S, et al. Pregnancy and lupus: prognostic indicators and response to treatment. Q J Med 1987; 66: 125-136.
9. Nilsson IM, Astedt B, Hedner U, Berezin D. Intrauterine death and circulating anticoagulant (“antithromboplastin”). Acta Med Scand 1975; 197: 153-159.
10. Cowchock S, Smith JB, Gocial B. Antibodies to phospholipids and nuclear antigens in patients with repeated abortions. Am J Obstet Gynecol 1986; 155: 1002-1010.
11. Harris EN, Loizou S, Englert H, et al. Anticardiolipin antibodies and lupus anticoagulant (letter). Lancet 1984; 2: 1099.
12. Harris EN, Gharavi AE, Boey ML, et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 2: 1211-1214.
13. Derue GJ, Englert HJ, Harris EN, et al. Fetal loss in systemic lupus: association with anticardiolipin antibodies. J Obstet Gynaecol 1985; 5: 207-209.
14. Lockshin MD, Druzin ML, Goei S, et al. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 1985; 313: 152-156.
15. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
16. Loizou S, McCrea JD, Rudge AC, Reynolds R, Boyle CC, Harris EN. Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. Clin Exp Immunol 1985; 62: 738-745.
17. Lockshin MD. Anticardiolipin antibodies in pregnant patients with systemic lupus erythematosus. (Letter). N Engl J Med 1986; 314: 1392-1393.
18. Robertson WB, Brosen I, Dixon G. Uteroplacental vascular pathology. Eur J Obstet Gynec Reprod Biol 1975; 5: 47-65.
19. Loizou S, Walport MJ. Antiphospholipid antibodies from patients with SLE and syphilis react homogeneously with different populations of phospholipids. Br J Rheumatol 1986; supplement 2: Abstract 9.
20. Can-eras LO, De-Freyn G, Machin SJ, et al. Arterial thrombosis, intrauterine death and “lupus” anti-coagulant. Detection of immunoglobulin interfering with prostacyclin formation. Lancet 1981; 1: 244-246.
21. Comp PC, Deboult LE, Esmon NL, Esmon CT. Human thrombomodulin is inhibited by IgG from two patients with non-specific anticoagulants. Blood 1983; Supplement 1: 1099.
22. Freyssinet JM, Wiesel ML, Gauchy J, Boneu B, Cazenave JP. An IgM lupus anticoagulant that neutralizes the enhancing effect of phospholipid on purified endothelial thrombomodulin activity - a mechanism for thrombosis. Thromb Haemost 1986; 55: 309-313.
23. Sanfelippo MJ, Drayna CJ. Prekallikrein inhibition associated with lupus anticoagulant: a mechanism of thrombosis. Am J Clin Pathol 1982; 77: 275-279.